Gilead Sciences
GILD
#129
Rank
HK$1.170 T
Marketcap
HK$943.13
Share price
-1.14%
Change (1 day)
36.86%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): HK$50.82

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is HK$50.73. In 2024 the company made an earnings per share (EPS) of HK$2.96 a decrease over its 2023 EPS that were of HK$35.40.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$50.821618.78%
2024HK$2.96-91.65%
2023HK$35.4023.98%
2022HK$28.55-25.86%
2021HK$38.514850%
2020HK$0.78-97.64%
2019HK$32.990.9%
2018HK$32.7018.71%
2017HK$27.54-64.88%
2016HK$78.43-18.45%
2015HK$96.1655.28%
2014HK$61.93296.02%
2013HK$15.6417.89%
2012HK$13.27

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
HK$101.38 99.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$111.49 119.79%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$10.52-79.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
HK$34.78-31.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$85.51 68.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$13.38-73.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$81.22 60.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$159.64 214.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$59.08 16.47%๐Ÿ‡บ๐Ÿ‡ธ USA